 |
|
|
| |
HIGH SVR RATES WITH THE COMBINATION OF ABT-493 + ABT-530 FOR 8 WEEKS IN NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1 OR 2 INFECTION
|
| |
| |
Reported by Jules Levin
Digestive Disease Week (DDW) • San Diego, CA • 21-24 May 2016
Fred Poordad1, Franco Felizarta2, Stanley Wang3, Armen Asatryan3,
Tarek Hassanein4, Humberto Aguilar5, Jacob Lalezari6, J Scott Overcash7, Teresa I Ng3, Sandra S Lovell3, Chih-Wei Lin3, Jens Kort3, Federico J Mensa3
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, United States; 2Private practice, Bakersfield, California, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4Southern California GI and Liver Centers and Southern California Research Center, Coronado, California, United States; 5Louisiana Research Center, Shreveport, Louisiana, United States; 6Quest Clinical Research, San Francisco, California, United States; 7eStudySite, San Diego, California, United States
|
| |
|
|
|
|
|
